NEW YORK, Feb. 26, 2018 -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against MiMedx Group, Inc. (“MiMedx” or the “Company”) (NASDAQ:MDXG) in the United States District Court for the Northern District of Georgia on behalf of a class consisting of investors who purchased or otherwise acquired MiMedx securities on the open market from March 7, 2013 through February 19, 2018, inclusive (the “Class Period”), seeking to recover compensable damages caused by Defendants’ violations of the Securities Exchange Act of 1934.
The Complaint alleges that in December of 2016, the Company was sued by two former employees alleging wrongful termination in relation to their reporting of a “channel-stuffing scheme” to “fraudulently recognize revenue” with regard to a particular distribution contract. The Company denied these claims. And in September 2017, when market analysts published reports purportedly corroborating these allegations, among others, the Company again denied any wrongdoing and sued for defamation.
On February 20, 2018, the Company announced that its audit committee “engaged independent legal and accounting advisors to conduct an internal investigation into current and prior-period matters relating to allegations regarding certain sales and distribution practices at the Company. The Company executives are also reviewing, among other items, the accounting treatment of certain distributor contracts.” On this news, the Company’s stock fell more than 39% to close at $8.75 on February 20, 2018.
Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm prior to the April 25, 2018 lead plaintiff motion deadline. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].
Please visit our website at http://www.gme-law.com for more information about the firm.


DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
OpenAI Restricts Astra AI Over Cyberattack Risks
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
Shein Scales Back Vietnam Operations as US Trade Rules Shift
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
DeepSeek to Raise AI API Prices as Demand for New Models Surges
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook 



